US Bancorp DE Reduces Position in Cooper Companies, Inc. (The) (COO)

US Bancorp DE cut its stake in Cooper Companies, Inc. (The) (NYSE:COO) by 6.8% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 27,350 shares of the medical device company’s stock after selling 2,008 shares during the period. US Bancorp DE owned 0.06% of Cooper Companies, Inc. (The) worth $6,548,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Dimensional Fund Advisors LP boosted its position in shares of Cooper Companies, Inc. (The) by 3.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 176,074 shares of the medical device company’s stock valued at $30,801,000 after buying an additional 6,448 shares during the last quarter. UBS Asset Management Americas Inc. boosted its position in shares of Cooper Companies, Inc. (The) by 34.4% in the fourth quarter. UBS Asset Management Americas Inc. now owns 812,106 shares of the medical device company’s stock valued at $142,062,000 after buying an additional 207,903 shares during the last quarter. Teachers Advisors LLC boosted its position in shares of Cooper Companies, Inc. (The) by 17.5% in the fourth quarter. Teachers Advisors LLC now owns 61,032 shares of the medical device company’s stock valued at $10,676,000 after buying an additional 9,089 shares during the last quarter. Kentucky Retirement Systems purchased a new position in shares of Cooper Companies, Inc. (The) during the fourth quarter valued at approximately $619,000. Finally, Kentucky Retirement Systems Insurance Trust Fund purchased a new position in shares of Cooper Companies, Inc. (The) during the fourth quarter valued at approximately $276,000. Institutional investors own 99.97% of the company’s stock.

Shares of Cooper Companies, Inc. (NYSE COO) traded up 0.39% during trading on Friday, reaching $240.92. 286,217 shares of the company traded hands. The stock has a market cap of $11.77 billion, a P/E ratio of 36.12 and a beta of 0.61. The stock’s 50 day moving average price is $245.14 and its 200-day moving average price is $214.89. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last posted its quarterly earnings results on Thursday, June 1st. The medical device company reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.25 by $0.25. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The business had revenue of $522.40 million for the quarter, compared to analysts’ expectations of $520.71 million. During the same quarter in the prior year, the business earned $2.05 EPS. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. On average, equities research analysts expect that Cooper Companies, Inc. will post $9.63 EPS for the current fiscal year.

The firm also recently declared a semiannual dividend, which was paid on Monday, August 7th. Investors of record on Friday, July 21st were paid a $0.03 dividend. This represents a yield of 0.02%. The ex-dividend date of this dividend was Wednesday, July 19th. Cooper Companies, Inc. (The)’s dividend payout ratio (DPR) is presently 0.90%.

COPYRIGHT VIOLATION WARNING: “US Bancorp DE Reduces Position in Cooper Companies, Inc. (The) (COO)” was posted by Stock Observer and is the property of of Stock Observer. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.thestockobserver.com/2017/08/12/us-bancorp-de-has-6-55-million-stake-in-cooper-companies-inc-the-coo-updated-updated.html.

COO has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $226.00 target price for the company in a report on Wednesday, May 3rd. Stifel Nicolaus increased their price target on shares of Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, June 2nd. Jefferies Group LLC reissued a “buy” rating and issued a $250.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Saturday, June 3rd. Oppenheimer Holdings, Inc. set a $225.00 price target on shares of Cooper Companies, Inc. (The) and gave the stock a “hold” rating in a research report on Saturday, June 3rd. Finally, BMO Capital Markets reissued an “outperform” rating and issued a $255.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $242.00.

In related news, Director Stanley Md Zinberg sold 816 shares of the stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $243.14, for a total value of $198,402.24. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Randal Golden sold 1,621 shares of the stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total value of $394,956.65. Following the completion of the sale, the vice president now owns 1,731 shares in the company, valued at approximately $421,758.15. The disclosure for this sale can be found here. In the last 90 days, insiders sold 67,331 shares of company stock worth $16,400,454. 1.60% of the stock is owned by company insiders.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply